Peter S. Nelson mostly deals with Prostate cancer, Cancer research, Prostate, Internal medicine and Androgen receptor. His study with Prostate cancer involves better knowledge in Cancer. His Cancer research research includes elements of Carcinogenesis, Gene, Signal transduction and Immunology.
His Prostate research integrates issues from Stromal cell and Tissue microarray. His Internal medicine study incorporates themes from Endocrinology and Oncology. His study explores the link between Androgen receptor and topics such as Dihydrotestosterone that cross with problems in Dehydroepiandrosterone.
Peter S. Nelson spends much of his time researching Prostate cancer, Cancer research, Internal medicine, Prostate and Androgen receptor. To a larger extent, he studies Cancer with the aim of understanding Prostate cancer. The Cancer research study combines topics in areas such as Phenotype, Carcinogenesis, Immunology, LNCaP and PTEN.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology. The study incorporates disciplines such as Erg, Gene expression, Bioinformatics and Adenocarcinoma in addition to Prostate. His work carried out in the field of Androgen receptor brings together such families of science as Receptor, Abiraterone acetate, Signal transduction and Tumor progression.
Peter S. Nelson focuses on Prostate cancer, Cancer research, Androgen receptor, Internal medicine and Oncology. His study on Prostate cancer is covered under Cancer. His Cancer research research integrates issues from Cell, DNA damage, Transcriptome, Castration resistant and Metastasis.
His Androgen receptor research incorporates elements of Testosterone, Regulation of gene expression, Downregulation and upregulation and Kinase. His research in the fields of Cohort, Abiraterone, Prostate-specific antigen and Survival analysis overlaps with other disciplines such as Score test. The various areas that Peter S. Nelson examines in his Oncology study include Exome sequencing, DNA sequencing, Disease and MEDLINE.
The scientist’s investigation covers issues in Prostate cancer, Cancer research, Androgen receptor, Internal medicine and Prostate. He combines Prostate cancer and TMPRSS2 in his studies. His biological study spans a wide range of topics, including Cancer, Metastasis, Suppressor, DNA repair and Bone marrow.
He has included themes like Androgen deprivation therapy and Downregulation and upregulation, Gene in his Androgen receptor study. Peter S. Nelson regularly ties together related areas like Oncology in his Internal medicine studies. His Prostate research is multidisciplinary, relying on both Prospective cohort study, Cohort study and Urology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell;Rachael K. Parkin;Evan M. Kroh;Brian R. Fritz;Brian R. Fritz.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe;Christopher K Patil;Francis Rodier;Francis Rodier;Yun-Yu Sun.
PLOS Biology (2008)
Integrative clinical genomics of advanced prostate cancer
Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz.
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
R. Bruce Montgomery;Elahe A. Mostaghel;Robert Vessella;David L. Hess.
Cancer Research (2008)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri;Sylvan C. Baca;Sylvan C. Baca;Michael S. Lawrence;Francesca Demichelis;Francesca Demichelis.
Nature Genetics (2012)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
Shunyou Wang;Jing Gao;Qunying Lei;Nora Rozengurt.
Cancer Cell (2003)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Colin C. Pritchard;Joaquin Mateo;Michael F. Walsh;Navonil De Sarkar.
The New England Journal of Medicine (2016)
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano.
Journal of Clinical Oncology (2016)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun;Cynthia C.T. Sprenger;Robert L. Vessella;Kathleen Haugk.
Journal of Clinical Investigation (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: